Wells Fargo & Company Increases Sabra Healthcare REIT (NASDAQ:SBRA) Price Target to $22.00

Sabra Healthcare REIT (NASDAQ:SBRA) had its price objective upped by investment analysts at Wells Fargo & Company from $21.00 to $22.00 in a report released on Thursday,Benzinga reports. The brokerage presently has an “overweight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s target price points to a potential upside of 10.57% from the company’s current price.

Several other equities research analysts have also recently issued reports on the company. Jefferies Financial Group reiterated a “buy” rating and issued a $22.00 price objective on shares of Sabra Healthcare REIT in a report on Monday, December 15th. Citizens Jmp raised their target price on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research report on Wednesday, February 18th. Citigroup lifted their price target on Sabra Healthcare REIT from $21.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, February 18th. Truist Financial increased their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a research note on Friday, March 13th. Finally, Cantor Fitzgerald raised their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a report on Tuesday, February 17th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, Sabra Healthcare REIT presently has an average rating of “Moderate Buy” and an average target price of $22.00.

Sabra Healthcare REIT Price Performance

Shares of NASDAQ:SBRA traded up $0.06 during midday trading on Thursday, reaching $19.90. 279,672 shares of the company’s stock traded hands, compared to its average volume of 2,778,421. The company has a fifty day simple moving average of $19.77 and a two-hundred day simple moving average of $19.07. Sabra Healthcare REIT has a 1 year low of $15.75 and a 1 year high of $21.07. The company has a market cap of $5.02 billion, a P/E ratio of 31.10, a PEG ratio of 1.57 and a beta of 0.64. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.29 and a current ratio of 4.29.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.26). The company had revenue of $201.35 million during the quarter, compared to analysts’ expectations of $201.97 million. Sabra Healthcare REIT had a return on equity of 5.63% and a net margin of 20.09%.Sabra Healthcare REIT’s revenue was up 16.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.36 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities analysts predict that Sabra Healthcare REIT will post 1.45 EPS for the current fiscal year.

Hedge Funds Weigh In On Sabra Healthcare REIT

A number of institutional investors have recently bought and sold shares of the company. Rothschild Investment LLC boosted its position in shares of Sabra Healthcare REIT by 164.6% during the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 889 shares during the period. Smartleaf Asset Management LLC raised its holdings in shares of Sabra Healthcare REIT by 97.7% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 714 shares during the period. Founders Capital Management acquired a new position in Sabra Healthcare REIT during the 3rd quarter worth about $28,000. Strengthening Families & Communities LLC acquired a new position in Sabra Healthcare REIT during the 4th quarter worth about $29,000. Finally, Danske Bank A S purchased a new position in Sabra Healthcare REIT during the 3rd quarter valued at about $30,000. 99.40% of the stock is owned by hedge funds and other institutional investors.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.